These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 23613886)

  • 21. Post-transplant hepatitis B virus reactivation impacts the prognosis of patients with hepatitis B-related hepatocellular carcinoma: a dual-centre retrospective cohort study in China.
    Li H; Lu D; Chen J; Zhang J; Zhuo J; Lin Z; Cao C; Shen W; He C; Chen H; Hu Z; Sun Y; Wei X; Zhuang L; Zheng S; Xu X
    Int J Surg; 2024 Apr; 110(4):2263-2274. PubMed ID: 38348848
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential impact of risk factors for tumor recurrence in hepatitis B and hepatitis C virus-infected patients undergoing liver transplantation for hepatocellular carcinoma.
    Krasnodębski M; Grąt M; Masior Ł; Patkowski W; Krawczyk M
    Ann Transplant; 2015 Feb; 20():70-5. PubMed ID: 25639825
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The impact of viral hepatitis-related hepatocellular carcinoma to post-transplant outcomes.
    Younossi ZM; Stepanova M; Saab S; Ahmed A; Lam B; Srishord M; Venkatesan C; Wai H; Henry L
    J Viral Hepat; 2016 Jan; 23(1):53-61. PubMed ID: 26289820
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predictors of survival after liver transplantation for hepatocellular carcinoma associated with Hepatitis C.
    Shimoda M; Ghobrial RM; Carmody IC; Anselmo DM; Farmer DG; Yersiz H; Chen P; Dawson S; Durazo F; Han S; Goldstein LI; Saab S; Hiatt J; Busuttil RW
    Liver Transpl; 2004 Dec; 10(12):1478-86. PubMed ID: 15558585
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of clinical manifestations and outcomes between hepatitis B virus- and hepatitis C virus-related hepatocellular carcinoma: analysis of a nationwide cohort.
    Sinn DH; Gwak GY; Cho J; Paik SW; Yoo BC
    PLoS One; 2014; 9(11):e112184. PubMed ID: 25372403
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatocellular Carcinoma in the Setting of Chronic Hepatitis B Virus Infection: Tumor Recurrence and Survival Rates After Liver Transplantation.
    Dugum M; Hanouneh I; Lopez R; Aucejo F; Eghtesad B; Zein N
    Transplant Proc; 2015; 47(6):1939-44. PubMed ID: 26293077
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of viral hepatitis-associated hepatocellular carcinoma due to HBV and HCV - cohort from liver clinics in Pakistan.
    Munaf A; Memon MS; Kumar P; Ahmed S; Kumar MB
    Asian Pac J Cancer Prev; 2014; 15(18):7563-7. PubMed ID: 25292029
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High-dose hepatitis B immunoglobulin therapy in hepatocellular carcinoma with hepatitis B virus-DNA/hepatitis B e antigen-positive patients after living donor liver transplantation.
    Lee EC; Kim SH; Lee SD; Park H; Lee SA; Park SJ
    World J Gastroenterol; 2016 Apr; 22(14):3803-12. PubMed ID: 27076765
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatocellular Carcinoma Is the Most Common Indication for Liver Transplantation and Placement on the Waitlist in the United States.
    Yang JD; Larson JJ; Watt KD; Allen AM; Wiesner RH; Gores GJ; Roberts LR; Heimbach JA; Leise MD
    Clin Gastroenterol Hepatol; 2017 May; 15(5):767-775.e3. PubMed ID: 28013117
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatitis B and C viruses and survival from hepatocellular carcinoma in the Arkhangelsk region: a Russian registry-based study.
    Makarova M; Krettek A; Valkov MY; Grjibovski AM
    Int J Circumpolar Health; 2013; 72():20282. PubMed ID: 23687637
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Infection with hepatitis C virus is an adverse prognostic factor after liver resection for early-stage hepatocellular carcinoma: implications for the management of hepatocellular carcinoma eligible for liver transplantation.
    Chirica M; Tranchart H; Tan V; Faron M; Balladur P; Paye F
    Ann Surg Oncol; 2013 Jul; 20(7):2405-12. PubMed ID: 23338483
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of prognosis by viral etiology in patients with hepatocellular carcinoma after radiofrequency ablation.
    Chen PH; Kao WY; Chiou YY; Hung HH; Su CW; Chou YH; Huo TI; Huang YH; Wu WC; Chao Y; Lin HC; Wu JC
    Ann Hepatol; 2013; 12(2):263-73. PubMed ID: 23396738
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Surgical results in patients with dual hepatitis B- and C-related hepatocellular carcinoma compared with hepatitis B- or C-related hepatocellular carcinoma.
    Chen MF; Jeng LB; Lee WC; Chen TC
    Surgery; 1998 May; 123(5):554-9. PubMed ID: 9591008
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comparison of survival and pathologic features of non-alcoholic steatohepatitis and hepatitis C virus patients with hepatocellular carcinoma.
    Hernandez-Alejandro R; Croome KP; Drage M; Sela N; Parfitt J; Chandok N; Marotta P; Dale C; Wall W; Quan D
    World J Gastroenterol; 2012 Aug; 18(31):4145-9. PubMed ID: 22919246
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The survival benefit of liver transplantation for hepatocellular carcinoma patients with hepatitis B virus infection and cirrhosis.
    Zhang Q; Chen X; Zang Y; Zhang L; Chen H; Wang L; Niu Y; Ren X; Shen Z; Shang L
    PLoS One; 2012; 7(12):e50919. PubMed ID: 23236406
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Outcome of liver transplantation for recipients with hepatitis B and hepatitis C virus coinfection: analysis of the UNOS data.
    Waki K; Sugawara Y; Tamura S; Mieno MN; Yamashiki N; Kadowaki T; Kokudo N
    Transplantation; 2011 Oct; 92(7):809-14. PubMed ID: 21832961
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A method for establishing allocation equity among patients with and without hepatocellular carcinoma on a common liver transplant waiting list.
    Vitale A; Volk ML; De Feo TM; Burra P; Frigo AC; Ramirez Morales R; De Carlis L; Belli L; Colledan M; Fagiuoli S; Rossi G; Andorno E; Baccarani U; Regalia E; Vivarelli M; Donataccio M; Cillo U;
    J Hepatol; 2014 Feb; 60(2):290-7. PubMed ID: 24161408
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Liver transplantation for hepatitis B virus: Decreasing indication and changing trends.
    Al-Hamoudi W; Elsiesy H; Bendahmash A; Al-Masri N; Ali S; Allam N; Al Sofayan M; Al Bahili H; Al Sebayel M; Broering D; Saab S; Abaalkhail F
    World J Gastroenterol; 2015 Jul; 21(26):8140-7. PubMed ID: 26185387
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Survival outcomes in liver transplantation for hepatocellular carcinoma, comparing impact of hepatitis C versus other etiology of cirrhosis.
    Bozorgzadeh A; Orloff M; Abt P; Tsoulfas G; Younan D; Kashyap R; Jain A; Mantry P; Maliakkal B; Khorana A; Schwartz S
    Liver Transpl; 2007 Jun; 13(6):807-13. PubMed ID: 17539001
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prophylaxis against hepatitis B virus recurrence after liver transplantation: a registry study.
    Shen S; Jiang L; Xiao GQ; Yan LN; Yang JY; Wen TF; Li B; Wang WT; Xu MQ; Wei YG
    World J Gastroenterol; 2015 Jan; 21(2):584-92. PubMed ID: 25593480
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.